Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL, Chang G (2009) Structure of P-glycoprotein reveals a molecular basis for polyspecific drug binding. Science 323:1718–1722
Google Scholar
Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev PharmacolToxicol 39:361–398
Google Scholar
Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Fagan P (2002) The protein data bank. ActaCrystallogr D BiolCrystallogr 58:899–907
Google Scholar
Brenneisen R (2007) Chemistry and analysis of phytocannabinoids and other cannabis constituents. In: ElSohly MA (ed) Marijuana and the Cannabinoids (Forensic Science and Medicine). Humana Press Inc, Totowa, New Jersey, pp 17–49
Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381–389
Google Scholar
Daina A, Olivier M, Vincent Z (2017) “SwissADME”: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717
Google Scholar
Dantzig A, Law KL, Cao J, Starling JJ (2001) Reversal of multidrug resistance by the Pglycoprotein modulator, LY335979, from the bench to the clinic. Curr Med Chem 8(1):39–50
Google Scholar
David TI, Adelakun NS, Omotuyi OI, Metibemu DS, Ekun OE (2018) Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR. Bioinformation 14(9):574–579
Google Scholar
Dolghih E, Bryant C, Renslo AR, Jacobson MP (2011) Predicting binding to P-glycoprotein by flexible receptor docking. PLoSComputBiol 7(6):e1002083
Google Scholar
Flores-Sanchez IJ, Verpoorte R (2008) Secondary metabolism in cannabis. Phytochem Rev 7:615–639
Google Scholar
Fox E, Bates SE (2007) Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor. Expert Rev Anticancer Ther 7:447–459
Google Scholar
Gadhe CG, Cho SJ (2011) Modulation of multidrug resistance in cancer by P-glycoprotein. J Chosun Natural Sci 4(1):23–30
Green LJ, Marder P, Slapak CA (2001) Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells. BiochemPharmacol 61(11):1393–1399
Google Scholar
Kast C, Canfield V, Levenson V, Gross P (1996) Transmembrane organization of mouse pglycoprotein determined by epitope insertion and immunofluorescence. J BiolChem 271:9240–9248
Google Scholar
Kharkar PS, Deodhar MN, Kulkarni VM (2009) Design, synthesis, antifungal activity, and ADME prediction of functional analogues of terbinafine. Med Chem Res 18(6):421–432
Google Scholar
Kim RB (2006) Transporters and drug discovery: why, when, and how. Mol Pharm 3:26–32
Google Scholar
Kim RB, Fromm MF, Wandel C, Leake B, Wood AJ, Roden DM, Wilkinson GR (1998) The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 101:289–294
Google Scholar
Leonard W, Zhang P, Ying D, Fang Z (2020) Lignanamides: sources, biosynthesis and potential health benefits–a minireview. Critical Reviews in Food Science and Nutrition 1–11.
Li YZ, Tong AP, Huang J (2012) Two new norlignans and a new lignanamide from Peperomiatetraphylla. ChemBiodivers 9:769–776
Google Scholar
Liu R, Siemiarczuk A, Sharom FJ (2000) Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides. Biochemistry 39:14927–14938
Google Scholar
Loo TW, Clarke DM (1994) Reconstitution of drug-stimulated ATPase activity following coexpression of each half of human P-glycoprotein as separate polypeptides. J BiolChem 269:7750–7755
Google Scholar
Loo TW, Clarke DM (1995) Membrane topology of a cysteine-less mutant of Human Pglycoprotein. J BiolChem 270:843–848
Google Scholar
Loo TW, Clarke DM (1996) The minimum functional unit of human P-glycoprotein appears to be a monomer. J BiolChem 271:27488–27492
Google Scholar
Loo TW, Clarke DM (1999) The transmembrane domains of the human multidrug resistance Pglycoprotein are sufficient to mediate drug binding and trafficking to the cell surface. J BiolChem 274:24759–24765
Google Scholar
Luo Q, Yan X, Bobrovskaya L, Ji M, Yuan H, Lou H, Fan P (2017) Anti-neuroinflammatory effects of grossamide from hemp seed via suppression of TLR-4-mediated NF-κB signaling pathways in lipopolysaccharide-stimulated BV2 microglia cells. Mol Cell Biochem 428(12):129–137
Google Scholar
Miller DS, Bauer B, Hartz AM (2008) Modulation of P-glycoprotein at the blood–brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev 60:196–209
Google Scholar
Molnar J, Szabo D, Pusztai R, Mucsi I, Berek L, Ocsovszki I, Kawata E, Shoyama Y (2000) Membrane associated antitumor effects of crocine, ginsenoside and cannabinoid derivates. Anticancer Res 20:861–867
Google Scholar
Nobili S, Landini I, Giglioni B, Mini E (2006) Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets 7:861–879
Google Scholar
Russo EB (2007) History of cannabis and its preparations in saga, science, and sobriquet. ChemBiodivers 4:1614–1648
Google Scholar
Sakakibara I, Katsuhara T, Ikeya Y, Hayashi K, Mitsuhashi H (1991) Cannabisin A, an arylnaphthalenelignanamide from fruits of Cannabis sativa. Phytochemistry 30(9):3013–3016
Google Scholar
Sakakibara I, Ikeya Y, Hayashi K, Mitsuhashi H (1992) Three phenyldihydronaphthalenelignanamides from fruits of Cannabis sativa. Phytochemistry 31(9):3219–3223
Google Scholar
Sakakibara I, Ikeya Y, Hayashi K, Okada M, Maruno M (1995) Three acyclic bis-phenylpropanelignanamides from fruits of Cannabis sativa. Phytochemistry 38:1003–1007
Google Scholar
Sharom FJ (2006) Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1). Biochem Cell Biol 84:979–992
Google Scholar
Shen J, Cheng F, Xu Y, Li W, Tang Y (2010) Estimation of ADME properties with substructure pattern recognition. J ChemInf Model 50:1034–1041
Google Scholar
Srivalli KMR, Lakshmi PK (2012) Overview of P-glycoprotein inhibitors: a rational outlook. Braz J Pharm Sci 48(3):353–367
Google Scholar
Thomsen R, Christensen MH (2006) Moldock: a new technique for high–accuracy molecular docking. J Med Chem 49(11):3315–3321
Google Scholar
Trott O, Olson AJ (2010) AutoDockVina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J ComputChem 31(2):455–461
Google Scholar
Wagner CC, Bauer M, Karch R, Feurstein T, Kopp S, Chiba P, Kletter K, Löscher W, Müller M, Zeitlinger M, Langer O (2009) A pilot study to assess the efficacy of tariquidar to inhibit Pglycoprotein at the human blood–brain barrier with (R)-11C-verapamil and PET. J Nucl Med 50:1954–1961
Google Scholar
Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. ProtEng 8:127–134
Google Scholar
Xia Y, Guo Y, Wen Y (2010) The total synthesis of cannabisin G. J Serb ChemSoc 75(12):1617–1623
Google Scholar
Yan X, Tang J, Dos Santos PC, Nurisso A, Simões-Pires CA, Ji M, Lou H, Fan P (2015) Characterization of lignanamides from hemp (Cannabis sativa L.) seed and their antioxidant and acetylcholine sterase inhibitory activities. J Agric Food Chem 63(49):10611–10619
Google Scholar
Zhou Y, Wang S, Lou H, Fan P (2018) Chemical constituents of hemp (Cannabis sativa L.) seed with potential anti-neuroinflammatory activity. PhytochemLett 23:57–61
Google Scholar
